Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Series C

Bolt latches onto series C financing
Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.
Mynd houses series C funding
Wells Fargo led a $41.5m round for the tech-equipped property manager that included existing backers Canaan Partners, Lightspeed Venture Partners and Jackson Square Ventures.
SolarisBank heats up with series C financing
Samsung Catalyst Fund, BBVA, SBI Group and ABN Amro Ventures chipped in as the banking platform developer raised $67.3m at a $360m valuation.
Novo gets in Freeline for $120m round
The pharmaceutical company co-led a series C round for AAV gene therapy developer Freeline that took its total funding to $275m.
Everbright Photonics lasers in on series C
Up Optotech-backed laser-diode chip foundry Everbright Photonics secured $21.2m in a round led by brokerage Huatai Securities.
Corporate venturing deal net: 22-26 June 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Somatus creates $64m series C round
The kidney care services provider has now collected more than $105m to date, Optum Ventures co-leading a round also featuring Blue Venture Fund.
UJet takes off with $55m
GV and Citi Ventures have helped the customer service platform developer nearly double its total funding to $100m by returning for a series C round led by Sapphire Ventures.

Other News

Immuta invites corporates to $40m series C
Intel Capital led a $40m round for the data management software provider while Dell Technologies Capital and Citi Ventures also invested.
DispatchHealth posts series C details
The home care provider has closed a round led by Optum Ventures and backed by Humana and Echo Health Ventures at approximately $136m.
Cedar sees its way to $102m
The series C round consisted of $77m in equity funding and $25m in venture debt, with Kaiser Permanente among the participants.
Surrozen scurries to $50m series C
Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.
Synqa sinks $80m in series C round
The digital fintech provider pulled in $80m through a series C round co-led by SCB 10X and backed by Aioi Nissay Dowa, Toyota Financial Services and Sumitomo Mitsui Banking Corporation.
CassTime shows class to raise $50m
The Fosun-backed automotive parts trading platform boosted its total series B funding to $130m with a series C2 round led by Greater Bay Area Homeland Investments.

Editor's Picks

Joby ascends with $590m
The aerial electric taxi developer increased its overall funding to $720m in a series C round led by a $394m investment from Toyota.
Sub-$50m Investment of the Year: Maana
Maana recently won GCV’s inaugural award for energy-tech corporate venture capital (CVC) investment of the year, presented during its Venture Houston conference in November. Now, Maana has gone one-stage further and won the Sub-$50m Investment of the Year award across all industries.
Relay Therapeutics runs away with $400m
SoftBank Vision Fund led a series C round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.
Zymergen climbs to $400m series C
The molecular product technology provider followed a nine-figure, SoftBank-led round two years ago with a series C led by the corporate's Vision Fund.
test reg